Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose

Transfer of the sodium iodide symporter (hNIS) has been proposed as a new principle of cancer gene therapy. Using clinically relevant doses of 131I for the treatment of NIS-expressing prostate carcinoma cells, we investigated the kinetics and the absorbed doses obtained in these tumors. hNIS-express...

Full description

Saved in:
Bibliographic Details
Main Authors: Haberkorn, Uwe (Author) , Kinscherf, Ralf (Author) , Kübler, Wolfgang (Author) , Eisenhut, Michael (Author) , Altmann, Annette (Author)
Format: Article (Journal)
Language:English
Published: 2003
In: Gene therapy
Year: 2003, Volume: 10, Issue: 9, Pages: 774-780
ISSN:1476-5462
DOI:10.1038/sj.gt.3301943
Online Access:Verlag, Volltext: http://dx.doi.org/10.1038/sj.gt.3301943
Verlag, Volltext: https://www.nature.com/gt/journal/v10/n9/full/3301943a.html
Get full text
Author Notes:U Haberkorn, R Kinscherf, M Kissel, W Kübler, M Mahmut, S Sieger, M Eisenhut, P Peschke, and A Altmann
Description
Summary:Transfer of the sodium iodide symporter (hNIS) has been proposed as a new principle of cancer gene therapy. Using clinically relevant doses of 131I for the treatment of NIS-expressing prostate carcinoma cells, we investigated the kinetics and the absorbed doses obtained in these tumors. hNIS-expressing cell lines accumulated up to 200 times more iodide when compared to wild-type cells. However, a rapid efflux of the radioactivity (80%) occurred during the first 20 min after replacement of the medium. In rats, the hNIS-expressing tumors accumulated up to 20 times more iodide when compared to contralateral transplanted wild-type tumors. After 24 h and doses of 550, 1200 or 2400 MBq/m2 hNIS-expressing tumors lost 89, 89 and 91% of the initial activity, respectively. Dosimetric calculations showed that 1200 MBq/m2 resulted in 30.5 Gy (wild-type tumor 0.150.1 Gy) and 2400 MBq/m2 resulted in 3.10.9 Gy (wild-type tumor 0.260.02 Gy). Although transduction of the hNIS gene induces iodide transport in rat prostate adenocarcinoma a rapid efflux occurs, which leads to a low absorbed dose in genetically modified tumors. With regard to a therapeutic application additional conditions need to be defined leading to iodide trapping.
Item Description:Gesehen am 19.10.2017
Physical Description:Online Resource
ISSN:1476-5462
DOI:10.1038/sj.gt.3301943